MedTrace Logo

The Effect of Cognitive Functions on Upper Extremity Functionality in Parkinson's Patients

NCT05872646 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2023-05-24

No results posted yet for this study

Summary

Parkinson's Disease (PD), first described by James Parkinson in 1817, is a progressive movement disorder that develops mainly as a result of the destruction of nigrostriatal dopaminergic neurons. The aim of our study is to determine the effect of cognitive functions on upper extremity functionality in individuals with Parkinson's Disease.

Conditions

Interventions

DIAGNOSTIC_TEST

clinical assessment

clinical staging

Sponsors & Collaborators

  • Pamukkale University

    lead OTHER

Principal Investigators

  • DUDU ŞIMŞEK · PhD student

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-08
Primary Completion
2023-03-10
Completion
2023-03-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05872646 on ClinicalTrials.gov